Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

28.4K
Overview
28.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ozone alters the allergenicity of Ambrosia artemisiifolia pollen in a dose-dependent manner.

Environment international·2026
Same author

Lower airway dysbiosis fuels NETosis in nontuberculous mycobacterial bronchiectasis: rethinking the microbiome-host axis.

American journal of respiratory and critical care medicine·2026
Same author

TNF Pathway-Mediated Tolerogenic T-Cell Trajectory Driven by Allergen Immunotherapy.

Allergy·2026
Same author

Defining in vivo and in vitro models for evaluating the sensitising potential of birch pollen extracts.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Advances in automatic airborne fungal spore monitoring: detection-efficiency test of the BAA500.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis.

The British journal of dermatology·2026

Related Experiment Video

Updated: Sep 3, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

Thermosensitive PLGA-PEG-PLGA Hydrogel as Depot Matrix for Allergen-Specific Immunotherapy.

Sonja Heine1, Antonio Aguilar-Pimentel2, Dennis Russkamp1

  • 1Center of Allergy and Environment (ZAUM), Technical University of Munich, School of Medicine and Helmholtz Center Munich, German Research Center for Environmental Health, 85764 Munich, Germany.

Pharmaceutics
|July 27, 2022
PubMed
Summary

A novel hydrogel delivery system for allergen-specific immunotherapy (AIT) offers a biodegradable and effective alternative to traditional treatments. This new approach reduces allergic inflammation and enhances protective antibody responses in a mouse model.

Keywords:
allergen-specific immunotherapyallergic asthmaantigen releasedelivery systemdepot matrixhydrogel

More Related Videos

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.7K
Generation and Recovery of β-cell Spheroids From Step-growth PEG-peptide Hydrogels
09:21

Generation and Recovery of β-cell Spheroids From Step-growth PEG-peptide Hydrogels

Published on: December 6, 2012

14.2K

Related Experiment Videos

Last Updated: Sep 3, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K
Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.7K
Generation and Recovery of β-cell Spheroids From Step-growth PEG-peptide Hydrogels
09:21

Generation and Recovery of β-cell Spheroids From Step-growth PEG-peptide Hydrogels

Published on: December 6, 2012

14.2K

Area of Science:

  • Immunology
  • Biomaterials Science
  • Allergy Research

Background:

  • Allergen-specific immunotherapy (AIT) is the sole curative treatment for allergies, often utilizing depot adjuvants to enhance efficacy.
  • Current adjuvants like aluminium salts raise health concerns and promote Th2 responses, necessitating safer alternatives.
  • Novel delivery systems are crucial for improving AIT efficacy and safety profiles.

Purpose of the Study:

  • To evaluate a novel triblock copolymer hydrogel as a delivery system for AIT.
  • To assess the hydrogel's depot function, biodegradability, and release kinetics of bioactive compounds.
  • To compare the therapeutic efficacy of hydrogel-based AIT with standard AIT in a murine model of allergic asthma.

Main Methods:

  • A triblock copolymer hydrogel was developed and characterized for its release properties in vitro and in vivo.
  • The hydrogel was used as a delivery vehicle for AIT in a murine model of allergic asthma.
  • Key allergic inflammation parameters, including cellular infiltration, mucus production, IgE, and IgG levels, were assessed.

Main Results:

  • The hydrogel demonstrated both depot function and biodegradability, releasing bioactive compounds effectively.
  • Hydrogel-based AIT significantly reduced inflammatory cell infiltration, mucus hypersecretion, and allergen-specific IgE.
  • Compared to standard AIT, hydrogel-based AIT induced higher levels of protective allergen-specific IgG antibodies.

Conclusions:

  • The hydrogel serves as a promising biodegradable delivery system for AIT, combining sustained allergen release with immunomodulation.
  • Hydrogel-based AIT achieves comparable efficacy to standard treatments while potentially offering enhanced protective immune responses.
  • This novel delivery system represents a significant advancement in developing safer and more effective AIT strategies.